Service de Chirurgie Viscérale Digestive et Urologique, Hôpital Victor Dupouy, Argenteuil, France.
Surg Endosc. 2010 Jan;24(1):51-62. doi: 10.1007/s00464-009-0511-6. Epub 2009 May 23.
No unanimous consensus has been achieved regarding the ideal management of cholecystocholedocholithiasis. The treatment of gallbladder and common bile duct (CBD) stones may be achieved currently according to a two-step-protocol (endoscopic sphincterotomy associated with laparoscopic cholecystectomy) or by a one-step laparoscopic procedure, including exploration of the CBD and cholecystectomy. Endoscopic sphincterotomy is reported to have considerable morbidity/mortality and CBD stone recurrence rates, whereas laparoscopic CBD clearance is a demanding procedure, which to date has not spread beyond specialized environments.
To evaluate our "laparoscopy first" (LF) approach for patients affected by gallbladder/CBD stones (laparoscopic exploration and intraoperative decision whether to proceed with laparoscopic CBD exploration or to postpone CBD stone treatment to a postoperative endoscopic retrograde cholangiopancreatography [ERCP]), we performed a retrospective, two-center case-control comparison of the postoperative outcome for 49 consecutive patients treated for gallbladder/CBD stones from January 2000 through December 2004. The results obtained with this LF approach were compared with those achieved with the traditional, "endoscopy-first" (EF) approach (ERCP plus endoscopic sphincterotomy, followed by laparoscopic cholecystectomy). The mean follow-up period was 6.4 years (range, 4-8 years).
No difference emerged concerning early and late complications, mortality, or laparotomies needed to accomplish cholecystectomy and CBD clearance. The postoperative hospital stay was shorter for the LF group. In the LF group, only 22 patients underwent choledochotomy (45%), and 15 patients underwent perioperative ERCP (30%). Conversions decreased with practice. After choledochotomy, an increasing number of patients underwent primary closure of the CBD (with no biliary drain), without complications.
An LF approach to gallbladder/CBD stones is safe and feasible. It may allow the majority of surgeons to avoid excessively difficult/dangerous surgical procedures as well as unnecessary ERCPs in most cases. A tendency toward a lower incidence of conversions and a rarer use of biliary drains may lead to an improved immediate outcome for patients undergoing an LF approach.
对于胆石性胆-胆总管结石的理想治疗方法,目前尚未达成一致共识。目前,胆囊和胆总管(CBD)结石的治疗可以采用两步法方案(内镜下括约肌切开术联合腹腔镜胆囊切除术)或一步法腹腔镜手术,包括胆总管探查和胆囊切除术。据报道,内镜下括约肌切开术有相当高的发病率/死亡率和 CBD 结石复发率,而腹腔镜 CBD 清除术是一种要求很高的手术,迄今为止尚未在普通环境中推广。
为了评估我们对患有胆囊/CBD 结石的患者采用的“腹腔镜优先”(LF)方法(腹腔镜探查和术中决定是否进行腹腔镜 CBD 探查或推迟 CBD 结石治疗至术后内镜逆行胰胆管造影[ERCP]),我们对 2000 年 1 月至 2004 年 12 月期间在两个中心接受治疗的 49 例连续胆囊/CBD 结石患者进行了回顾性病例对照比较。将通过这种 LF 方法获得的结果与传统的“内镜优先”(EF)方法(ERCP 加内镜下括约肌切开术,然后行腹腔镜胆囊切除术)的结果进行比较。平均随访时间为 6.4 年(范围,4-8 年)。
早期和晚期并发症、死亡率或需要剖腹手术才能完成胆囊切除术和 CBD 清除术方面无差异。LF 组的术后住院时间较短。在 LF 组中,只有 22 例患者(45%)进行了胆总管切开术,15 例患者(30%)进行了围手术期 ERCP。随着实践的进行,中转率有所下降。胆总管切开术后,越来越多的患者选择行 CBD 一期缝合(无需胆管引流),无并发症发生。
对胆囊/CBD 结石采用 LF 方法是安全可行的。它可能使大多数外科医生能够避免在大多数情况下进行过于困难/危险的手术和不必要的 ERCP。LF 方法的转化率较低,胆管引流的使用较少,可能会改善接受 LF 方法治疗的患者的即时结果。